CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-03 | Kalb Michael Wayne SVP and CFO | Grant or award · Stock Option (Right to Buy) | +96,500 | 96,500 | ||
| 2020-02-03 | Berg Aaron CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +96,500 | 96,500 | ||
| 2020-01-31 | THERO JOHN F President and CEO | Option exercise | +119,666 | 2,461,951 | ||
| 2020-01-31 | THERO JOHN F President and CEO | Option exercise | +123,667 | 2,585,618 | ||
| 2020-01-31 | THERO JOHN F President and CEO | Option exercise | +72,034 | 2,657,652 | ||
| 2020-01-31 | THERO JOHN F President and CEO | Shares withheld for taxes | −124,287 | $19.04 | $2.4M | 2,533,365 |
| 2020-01-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −119,666 | 0 | ||
| 2020-01-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −123,667 | 123,666 | ||
| 2020-01-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −72,034 | 144,066 | ||
| 2020-01-31 | Kennedy Joseph T General Counsel | Option exercise | +36,000 | 161,723 | ||
| 2020-01-31 | Kennedy Joseph T General Counsel | Option exercise | +26,000 | 187,723 | ||
| 2020-01-31 | Kennedy Joseph T General Counsel | Option exercise | +12,734 | 200,457 | ||
| 2020-01-31 | Kennedy Joseph T General Counsel | Shares withheld for taxes | −39,632 | $19.04 | $755K | 160,825 |
| 2020-01-31 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −36,000 | 0 | ||
| 2020-01-31 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −26,000 | 26,000 | ||
| 2020-01-31 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −12,734 | 25,466 | ||
| 2020-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +29,000 | 482,969 | ||
| 2020-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +26,000 | 508,969 | ||
| 2020-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +12,734 | 521,703 | ||
| 2020-01-31 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −33,603 | $19.04 | $640K | 488,100 |
Page 58 of 67 · 1,339 trades